ViroGates A/S (VIROG)

Currency in DKK
10.50
-0.40(-3.67%)
Real-time Data·

VIROG Earnings

Latest Release
Aug 20, 2026
EPS / Forecast
-0,06 / --
Revenue / Forecast
4,02M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/----/------Free Sign Up
2026/06-0,060/--4,02M/------Free Sign Up
2026/03-0,280/--1,30M/------Free Sign Up
2025/12-0,260/--2,36M/------Free Sign Up
2025/09-0,250/--1,67M/------Free Sign Up
2025/06-0,420/--3,67M/------Free Sign Up
2025/03-0,360/--1,20M/------Free Sign Up
2024/12-0,570/--1,57M/------Free Sign Up
2024/09--/----/------Free Sign Up
2024/06--/----/------Free Sign Up

All numbers in DKK

ViroGates A/S Earnings Call Summary for Q2/2026

  • ViroGates H1 2026 revenue surged 173% to DKK 5.1M, driven by large U.S. partner order; operating loss narrowed 33% to DKK 3.9M; shares rose 6.4%.
  • Company shifting from direct clinic sales to partnership-led distribution model; cash position strengthened to DKK 17.6M from DKK 11.9M year-over-year.
  • Full-year 2026 revenue guidance set at DKK 6.5M-8.0M; H2 expected below H1 due to non-recurring nature of suPARbio order.
  • FDA requested additional data for suPARnostic TurbiLatex De Novo application; partner Sobi helping fund regulatory work with minimal cash impact.
  • Revenue concentration risk remains high with single partner driving growth; recurring customer base flat at 20, raising concerns about diversification.
Last Updated: 2026/08/21, 12:00
Read Full Transcript

FAQ

What Is ViroGates's Earnings Per Share (TTM)?

The ViroGates EPS (TTM) is -0,82.

When Is The Next ViroGates Earnings Date?

ViroGates will release its next earnings report on Nov 05, 2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.